Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Doxorubicin × 30 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 11 Burkitt Lymphoma 10 Neoplasms 8 Lymphoma, Follicular 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Hodgkin Disease 4 Fallopian Tube Neoplasms 4 Sarcoma 3 Recurrence 3 Lymphoma, B-Cell, Marginal Zone 3 Liposarcoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Endometrial Neoplasms 3 Sarcoma, Ewing 2 Osteosarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Thymoma 1

Interventions

Nivolumab 18 cabozantinib 14 Magnetic Resonance Spectroscopy 14 Specimen Handling 12 Ipilimumab 12 pembrolizumab 11 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 trastuzumab deruxtecan 1 temsirolimus 1 sitravatinib 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡